Table.Briefings Suche

Feedback geben
Erweiterte Suchoptionen
Briefings
Zeitraum
Zurücksetzen

Sinovac: Zweifel am Corona-Impfstoff

Der chinesische Impfstoffhersteller Sinovac kann die zunächst angenommene Wirksamkeit seines Corona-Impfstoffs nicht glaubwürdig nachweisen. Das verunsichert die Bevölkerung vor allem in Schwellenländern, die Sinovac beliefern will.

Von

Die drei Kandidaten für den CDU-Vorsitz: Laschet, Merz, Röttgen

CDU: the China candidate check

Three candidates for the office of CDU chairman and their stance on China policy: Armin Laschet stands for continuity and "change through trade," Friedrich Merz focuses on a consistent China strategy for Europe, and Norbert Roettgen is expected to be clearly critical of the leadership in Beijing.

Von Redaktion Table

Sinovac: doubts on Covid vaccine

The Chinese vaccine manufacturer Sinovac cannot credibly prove the initially assumed effectiveness of its Covid vaccine. This unsettles the population, especially in emerging countries that Sinovac wants to supply.

Von

Technologies to drive growth in 2021

China's economic growth will pick up speed in 2021. Experts expect the government's new five-year plan to provide incentives for investment, including for foreigners. The focus will be on smart manufacturing, artificial intelligence, cloud technologies, smart mobility and renewable energies. Beijing also focuses on research cooperation.

Von Redaktion Table